Randomized phase II trial of two sequential schedules of docetaxel and cisplatin followed by gemcitabine in patients with advanced non-small cell lung cancer

Trial Profile

Randomized phase II trial of two sequential schedules of docetaxel and cisplatin followed by gemcitabine in patients with advanced non-small cell lung cancer

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Feb 2012

At a glance

  • Drugs Cisplatin; Docetaxel; Gemcitabine
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Sponsors Sanofi
  • Most Recent Events

    • 15 Dec 2008 Actual patient number identified as 88 from ClinicalTrials.gov.
    • 15 Dec 2008 Actual trial completion date identified as August 2008 from ClinicalTrials.gov.
    • 15 Dec 2008 Status changed from active, no longer recruiting to completed according to ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top